share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Arduini Peter J

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Arduini Peter J

施贵宝 | 4：持股变动声明-董事 Arduini Peter J
SEC announcement ·  04/02 18:41
Moomoo AI 已提取核心信息
Peter J Arduini, a reporting person for Bristol-Myers Squibb (BMY), has engaged in a transaction involving the company's stock. The action took place on March 31, 2024. However, the specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting ownership stake, have not been disclosed. This information is critical for investors to understand the implications of the transaction on their investment decisions.
Peter J Arduini, a reporting person for Bristol-Myers Squibb (BMY), has engaged in a transaction involving the company's stock. The action took place on March 31, 2024. However, the specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting ownership stake, have not been disclosed. This information is critical for investors to understand the implications of the transaction on their investment decisions.
百时美施贵宝（BMY）的举报人彼得·阿杜尼参与了一项涉及该公司股票的交易。该行动于 2024 年 3 月 31 日进行。但是，有关交易性质的具体细节，例如所涉及的股票数量、交易价格以及由此产生的所有权，尚未披露。这些信息对于投资者了解交易对其投资决策的影响至关重要。
百时美施贵宝（BMY）的举报人彼得·阿杜尼参与了一项涉及该公司股票的交易。该行动于 2024 年 3 月 31 日进行。但是，有关交易性质的具体细节，例如所涉及的股票数量、交易价格以及由此产生的所有权，尚未披露。这些信息对于投资者了解交易对其投资决策的影响至关重要。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息